J Clin Neurol.  2018 Jan;14(1):98-99. 10.3988/jcn.2018.14.1.98.

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis

Affiliations
  • 1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health, University of Genova, Genova, Italy. martina.garnero@hotmail.it

Abstract

No abstract available.

Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr